FOXO Technologies (FOXO Technologies) Notes Receivable : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is FOXO Technologies Notes Receivable?

FOXO Technologies's Notes Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

FOXO Technologies Notes Receivable Historical Data

The historical data trend for FOXO Technologies's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FOXO Technologies Notes Receivable Chart

FOXO Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Notes Receivable

FOXO Technologies Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Notes Receivable	Get a 7-Day Free Trial								-	-	-	-	-

FOXO Technologies Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

FOXO Technologies Notes Receivable Related Terms

Thank you for viewing the detailed overview of FOXO Technologies's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

FOXO Technologies (FOXO Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » FOXO Technologies Inc (AMEX:FOXO) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

729 Washington Avenue N, Suite 600, Minneapolis, MN, USA, 55401

Website

https://www.foxolife.com

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging.

Executives

Martin Christopher Ward	officer: Interim CFO	CHALKSTREAM, KINGS SOMBORNE, STOCKBRIDGE X0 S020 6NZ
Mark Brian White	director, officer: Interim CEO	IMMEUBLE MILA, CHAMPERY V8 1874
Dowling Vincent J. Jr	10 percent owner	54 LEDYARD, WEST HARTFORD CT 06117
Gwg Holdings, Inc.	10 percent owner	325 N. ST. PAUL STREET, SUITE 2650, DALLAS TX 75201
Taylor Fay	officer: Chief Operating Officer	729 N. WASHINGTON AVE, SUITE 600, MINNEAPOLIS MN 55401
Jon Sabes	director, 10 percent owner, officer: CEO, Chairman	701 NORTH THIRD STREET, MINNEAPOLIS MN 55401
Bret Barnes	director	220 SOUTH SIXTH STREET, MINNEAPOLIS MN 55402
Brian Chen	officer: Chief Science Officer	220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Erin Sharoni	officer: Chief Product Officer	220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Michael Will	officer: General Counsel	220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Tyler Danielson	officer: Chief Technology Officer	220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Murdoc Khaleghi	director	220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Robert Potashnick	officer: Chief Financial Officer	220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Plc Barclays	10 percent owner	1 CHURCHILL PLACE, CANARY WHARF, LONDON X0 E14 5HP
Paul Britton Newhouse	director	ONE CITY CENTRE, 1021 MAIN STREET SUITE 1960, HOUSTON TX 77002

FOXO Technologies (FOXO Technologies) Headlines

From GuruFocus

Thinking about buying stock in AMC Entertainment, Evolve Transition Infrastructure, Silicom, Foxo Technologies, or Yellow?

By PRNewswire • 08-02-2023